BuzzSparks.org

Elevation Pharmaceuticals


biopharmaceutical company

Founded in 2008, Elevation Pharmaceuticals is developing a pipeline of improved aerosol drug products for COPD patients. There founding team has a successful track record starting companies and building dedicated teams to develop new drug products...

Founded in 2007
Homepage:
Total money raised: $89.4M

HQ

92130 12671 High Bluff Drive
Ste 200

San Diego
San Diego
USA CA

Phone: 858-436-1616

Updated on Sep 19, 2013
Elevation Pharmaceuticals at CrunchBase
Bill Gerhart President & CEO
Past
Heath Lukatch Board of Directors
Brent Ahrens Board of Directors

August, 2012

Elevation Pharmaceuticals was acquired by Sunovion Pharmaceuticals
for $430M

Investors Cash In as Sunovion Acquires Elevation Pharmaceuticals    pevc.dowjones.com

January, 2012

Elevation Pharmaceuticals raised $30M in a Series B round from Novo Ventures, Canaan Partners, TPG Biotech, Care Capital, and Mesa Verde Venture Partners

Elevation Pharmaceuticals Completes $30 Million Series B Financing to Advance Aerosol COPD Therapy    elevationpharma.com

December, 2011

Elevation Pharmaceuticals raised $12.4M in partial round

SEC    sec.gov

September, 2011

Elevation Pharmaceuticals raised $17M in a Series A round from Canaan Partners, TPG Growth, Care Capital, and Mesa Verde Venture Partners

Elevation Pharma Pulls in $17M to Advance Lung Drug Trial    xconomy.com

January, 2010

Elevation Pharmaceuticals raised $30M in a Series A round from Canaan Partners, TPG Growth, Care Capital, and Mesa Verde Venture Partners

Elevation Pharmaceuticals Raises $30M in Series A Financing    finsmes.com

2007

Elevation Pharmaceuticals was founded in 2007